CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Eurobio Scientific SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Eurobio Scientific SA
Les Ulis Cedex
Phone: +33 1169796480p:+33 1169796480 LES ULIS, 91953  France Ticker: ALERSALERS
Business Summary
Eurobio Scientific SA, formerly Diaxonhit, is a France-based biotechnology company engaged in the field of in-vitro diagnostic. It is engaged in activities ranging from discovery to the commercialization of specialty diagnostic products. The Company owns a portfolio of diagnostic products in three specialty areas: infectious diseases; Alzheimer's disease, and cancer. It consists of Tetanos Quick Stick (TQS), which is an unitary test enabling to determine the tetanus vaccination status. It has a portfolio of in-house and co-developed products, including AclarusDx (a blood-based test for the detection of biomarkers specific for Alzheimer's disease). The portfolio includes BJI Inoplex for prosthetic infections and EHT Dx14 for breast cancer (both in validation phase). The co-developed products include research programs for the identification of predictive biomarkers of response for anti-HER2 and anti-angiogenic therapies, among others. It operates through Genbio and Eurobio Capforce Plus.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer DenisFortier 55 1/1/2023 6/27/2019
General Manager, President of EurobioNext, Director Jean-Michel C.Grandmougin 62 1/1/2023 3/30/2017
Director HerveDuchesne De Lamotte 66 11/1/2023 11/4/2009
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Biomedical Diagnostics NV Ahlers House Antwerp Belgium
InGen BioSciences Group 17 Avenue du Parc Chilly-Mazarin France
Eurobio 7 avenue de Scandinavie Les Ulis France
Genome Diagnostics B.V. Yalelaan 48 Utrecht Netherlands
Innominata 15222 Avenue Of Science San Diego CA United States

Business Names
Business Name
ALEHT
ALERS
ALETT
8 additional Business Names available in full report.

General Information
Number of Employees: 137 (As of 12/31/2023)
Outstanding Shares: 10,922,805 (As of 12/31/2023)
Stock Exchange: EPA
Fax Number: +33 158054719


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024